Tag: $Danaher

Danaher Corporation shares rose in premarket trading on Wednesday after the life sciences and diagnostics company reported third-quarter adjusted earnings of $2.11 per share, beating analyst expectations of $1.92.

Danaher Corporation (DHR) reported first-quarter results that beat earnings expectations but fell short on revenue, sending shares as much as 3.8% lower in premarket trading before a recovery, with the stock now down around 0.3%.

Danaher announced on Monday that it agreed to acquire biotech company Abcam in a deal valued at $5.7 billion.